My colleagues and I have a new brief report in American Journal of Public Health!
The main takeaway:
Data from NCI’s HINTS shows #eHealth engagement varies by type and among population groups, suggesting ongoing inequities and potential exclusion from digital health interventions and digitally-based health research
The article has been published online ahead of print here. If you don't have access to the full article, here's a copy.
Do cancer patients know how genetic testing can inform their treatment decisions? Research overall suggests that many do not.
This summer I had the opportunity to work as a research assistant in Dr. Kimberly Kaphingst’s lab at the Huntsman Cancer Institute in Salt Lake City. I helped with research projects examining the current state of communication research in the area of cancer genetics.
I also had the chance to present results from our genetic cancer communication scoping review at the HCI Trainees Symposium. We summarized papers in this area and will make that summary available to the public soon.
HCI was recently named one of the most beautiful hospitals in the U.S., and it’s no wonder!
I took full advantage of the back patio for work afternoons overlooking the foothills, mountain bikers, blue skies and birds.
Huntsman Cancer Institute was named one of the top 10 most beautiful hospitals in the nation! https://t.co/myFEB9v9HX pic.twitter.com/f8NjDZLtwu
— Huntsman Cancer Inst (@huntsmancancer) July 23, 2018
This past May at the International Communication Association‘s annual meeting, I got to present the latest version of a meta-analysis of studies examining the potential for narrative messages to lower resistance to persuasion.
My coauthor Dr. Ye Sun and I received two awards for the paper: top student-led paper in health communication, and one of the top four papers in health communication.
Curious about the findings of our analysis? In short: narratives had a small but significant advantage over non-narratives when it came to reducing resistance to persuasion—which is either exciting or cause for caution, depending on how you look at it!
We also found that the association between higher narrative engagement and lower resistance held up across studies. In other words, when people are more transported into a story or are identifying with the main characters, there’s a good chance they’ll be more persuadable. Across studies, there were several moderators of these effects, which we’ll reveal in the manuscript once it’s published.
Winning awards in the Health Communication division was a great honor, and it was also a great excuse to visit Prague for the first time!
Speaking of the power of stories, the streets of Prague seem to be filled with Kafka references…
Repost of University of Utah’s Communication Dept. announcement:
Communication Dept. Scholars Publish on the Critical Role of Communication in the “Precision Medicine Era”
Precision medicine is the notion of a precise approach to healthcare—one that takes into account individual genetics, environments, and behaviors. As we enter this era of highly personalized care, there will likely be opportunities to take our health to new heights. But there may also be unforeseen consequences.
To date, little is known about how healthcare consumers will respond to highly personalized guidance and treatment. The assumption is that responses will generally be favorable. Yet in the media and in online public discussions about precision medicine, concerns have been raised about invasions of privacy and autonomy.
What challenges could arise as precision medicine is implemented in research trials and clinical settings? And can we address them, or prevent them, through better communication?
These questions are explored in a recent paper published in the Journal of Health Communication. The authors—Communication PhD student Chelsea Ratcliff and professors Kim Kaphingst and Jakob Jensen—highlight the potential for patient alienation in certain precision medicine contexts, especially among minority groups. They offer an agenda for research to guide communication with patients and the public, in order to foster understanding of precision medicine and informed participation in precision medicine initiatives.
In engaging these important questions, scholars from across disciplines can help bring ethical concerns and patient perspectives to the planning and implementation of precision medicine, ensuring medical and technological advances that are fair and beneficial for all.
…
The article can be found here: Ratcliff et al 2018.
Lucky us, it was included in the CDC’s Health Communication Digest!
